B. Braun Melsungen CEO Leads Historic Medtech Firm

Anna Maria Braun, a sixth-generation family member, leads B. Braun Melsungen as CEO of the medical device company. She also owns 10% of the company and presides over its operations in the Asian/Pacific region. B. Braun Melsungen's origins trace back to 1839, when it began as a modest pharmacy selling herbal remedies. Under the leadership of Anna Maria Braun's father, Ludwig Georg Braun, who took charge in 1977, the company has undergone substantial growth. At that time, annual sales were $24 million. Presently, B. Braun Melsungen generates approximately $8 billion in annual sales. With a global workforce exceeding 64,000 employees, the company manufactures a diverse portfolio of products, including infusion and injection solutions, as well as surgical instruments.